Found: 14
Select item for more details and to access through your institution.
Novel Wnt modulators for the treatment of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.063223
- By:
- Publication type:
- Article
Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Activation of FAK/Rac1/Cdc42‐GTPase signaling ameliorates impaired microglial migration response to Aβ<sub>42</sub> in triggering receptor expressed on myeloid cells 2 loss‐of‐function murine models.
- Published in:
- FASEB Journal, 2020, v. 34, n. 8, p. 10984, doi. 10.1096/fj.202000550RR
- By:
- Publication type:
- Article
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 529, p. 1, doi. 10.1126/scitranslmed.aay1809
- By:
- Publication type:
- Article
Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids.
- Published in:
- Acta Neuropathologica, 2021, v. 142, n. 5, p. 807, doi. 10.1007/s00401-021-02361-9
- By:
- Publication type:
- Article
Dentate Gyrus Contributes to Retrieval as well as Encoding: Evidence from Context Fear Conditioning, Recall, and Extinction.
- Published in:
- Journal of Neuroscience, 2017, v. 37, n. 26, p. 6359, doi. 10.1523/JNEUROSCI.3029-16.2017
- By:
- Publication type:
- Article
APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 613, p. 1, doi. 10.1126/scitranslmed.abc9375
- By:
- Publication type:
- Article
Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00640-5
- By:
- Publication type:
- Article
Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19264-0
- By:
- Publication type:
- Article
Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00599-3
- By:
- Publication type:
- Article
Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00577-1
- By:
- Publication type:
- Article
APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2020, v. 15, n. 1, p. N.PAG, doi. 10.1186/s13024-020-00413-4
- By:
- Publication type:
- Article